首页> 外文期刊>Der Pharmacia Lettre >Potential Impact of Talbina on Pituitary-Adrenal-Gonadal Disorders in Hypothyroid Adult Female Rats
【24h】

Potential Impact of Talbina on Pituitary-Adrenal-Gonadal Disorders in Hypothyroid Adult Female Rats

机译:Talbina对甲状腺功能低下成年雌性大鼠垂体-肾上腺-性腺疾病的潜在影响

获取原文
           

摘要

Hypothyroidism can impair pituitary-gonadal-adrenal function in adult female rats. Purpose: This study is designed to investigate the possible ameliorating effect of talbina on pituitary-gonadal-adrenal disorders as well as the oxidative stress which induced by hypothyroidism in adult female rats. Methods: Adult female albino rats were divided into 4 groups; Euthyroid intact control group, Euthyroid group orally administered talbina (100 mg.kg-1.day-1), hypothyroid group (received daily 5.0 mg kg-1 NeoMercazole®,) and hypothyroid +talbina group (orally co- administered 5.0 mg.kg-1 plus 100 mg.kg-1 talbina).Treatment with talbina started after one month from hypothyroid induction for consecutive 30 days. Results revealed that NeoMercazole® exhibited a state of hypothyroidism, induced significant depletion in serum estradiol; follicle-stimulating hormone levels in contrast a significant elevation in corticosterone and prolactin, elevation in serum extracellular regulate kinase 1/2 (ERK1/2) and evoked an oxidative stress status by elevating serum 8-hydroxy guanosine which initiated apoptosis by elevating serum apoptotic marker Caspase-3, with respect to control group. The treatment with talbina showed a significant ameliorative effect, which reversed the exacerbated effect of hypothyroidism by alleviating the disruption of thyroid, gonadal and adrenal functions and enhanced the protection against oxidative stress and apoptosis. Conclusion: these results evidenced that talbina acted on multi arrays for protecting the physiological functions against hypothyroid adverse impact.
机译:甲状腺功能减退症可损害成年雌性大鼠的垂体-性腺-肾上腺功能。目的:本研究旨在探讨塔比娜对成年雌性大鼠垂体-性腺-肾上腺疾病以及甲状腺功能减退所引起的氧化应激可能的改善作用。方法:成年雌性白化病大鼠分为4组。甲状腺功能正常的对照组,甲状腺功能正常的组口服塔比纳(100 mg.kg-1.day-1),甲状腺功能减退组(每天接受5.0 mg kg-1NeoMercazole®)和甲状腺功能减退症+塔比纳组(口服共给药5.0 mg)。 kg-1加100 mg.kg-1 talbina)。从甲状腺功能减退诱导开始的一个月后连续30天开始用talbina治疗。结果显示,NeoMercazole®表现为甲状腺功能减退状态,引起血清雌二醇的大量消耗。相比之下,促卵泡激素水平显着升高,皮质酮和催乳激素水平升高,血清细胞外调节激酶1/2(ERK1 / 2)升高,并通过升高血清8-羟基鸟苷引起氧化应激状态,后者通过升高血清凋亡标记物引发细胞凋亡。 Caspase-3,相对于对照组。塔比纳治疗显示出显着的改善作用,通过减轻甲状腺,性腺和肾上腺功能的破坏并增强了对氧化应激和细胞凋亡的保护作用,逆转了甲状腺功能减退症的恶化作用。结论:这些结果证明了塔比娜在保护甲状腺功能不受甲状腺功能不良影响的多种阵列上起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号